This study describes the isolation of equine herpesvirus-2 (EHV-2) from the lung of an aborted equine fetus in Argentina. The isolated virus was confirmed as EHV-2 by indirect immunofluorescence using a rabbit anti-EHV-2 polyclonal antiserum and by virus-neutralization test using an equine polyclonal antibody against EHV-2. Restriction endonuclease DNA fingerprinting with BamHI also confirmed the identity of the virus as EHV-2. Furthermore, viral nucleic acid was detected by polymerase chain reaction from the original lung sample and from the DNA obtained from cells infected with the virus isolate. This work constitutes the first reported isolation of EHV-2 from an aborted equine fetus. The presence of EHV-2 in the lung of the aborted fetus would indicate that this virus is capable of crossing the placental barrier. However, no cause-effect relationship was established between the EHV-2 isolate and the abortion.
The horse is the natural host for 5 recognized herpesviruses: equine herpesviruses 1, 3, and 4 (EHV-1, EHV-3, and EHV-4) belong to the Alphaherpesvirinae subfamily, whereas EHV-2 and EHV-5 are classified within the Gammaherpesvirinae subfamily. 18, 20, 21 The EHV-1 and EHV-4 are major causes of abortion and respiratory disease, respectively, and they are of considerable economic importance worldwide. Equine herpesvirus-3 (equine coital exanthema virus) is the causative agent of a relatively mild genital exanthema of both mares and stallions. In Argentina, EHV-1 and EHV-4 have been isolated from aborted fetuses, stillborn foals, and horses, with respiratory disease. The EHV-3 was isolated for the first time in Argentina from thoroughbred horses in training, suffering from unilateral rhinitis. 2, 8, 11 The EHV-2 infection occurs soon after birth, often in the presence of maternal antibodies. 16 The prototype strain of EHV-2 (LKV), the first gammaherpesvirus recovered from the horse, was isolated in 1962 from the respiratory tract of a foal with ''catarrh and coughing.'' 3 The virus has been isolated from leukocytes and various organs of healthy animals or horses with upper respiratory disease signs, anorexia, serous nasal discharge, conjunctivitis, fever and pneumonia, general malaise, and poor performance. [4] [5] [6] [7] Equine herpesvirus-2 may play a role as a predisposing factor for other infections such as Rhodococcus equi infection. 14 has also been suggested that EHV-2 may play a role in transactivation and reactivation of latent EHV-1 and EHV-4 infections. 9 Prenatal infection with EHV-2 has not been recorded, and the virus has not been detected in colostrum or milk. There is no evidence that EHV-2 has abortigenic potential. Experimental infection of a mid-gestational equine fetus in utero resulted in normal term delivery, although the foal showed mild rhinitis and conjunctivitis, with nasal shedding of EHV-2. 13, 19 Similar to EHV-2, EHV-5 infection has been associated with upper respiratory disease, and the 2 viruses can simultaneously coinfect the same individual. Both the viruses are slow growing in primary isolation; they remain highly cell associated and cannot be differentiated by their growth properties in cell culture. 9 A high prevalence of neutralizing antibodies against EHV-2 (up to 90%) has been reported in horses worldwide, and the virus has been isolated from circulating leukocytes in 89% of adult horses in the United States, 86% in Scotland, 90% in England, 55% in Japan, and 77% in Switzerland. 3 In Australia and the UK, 97% of examined abattoir horses harbored the virus in their lymphoid cells. 15 . In Argentina, the serological prevalence is 80%, and the virus has been isolated from animals with respiratory disease and detected by polymerase chain reaction (PCR) from nasal swab samples (Craig, unpublished data).
This study describes the isolation of EHV-2 from the lung of an aborted fetus. Pieces of lung, liver, and spleen were collected at necropsy from an aborted fetus submitted from a farm located in the Province of Buenos Aires. The samples were investigated for the presence of infectious virus by inoculation of supernatant into rabbit kidney (RK13) cells, and cytopathic effects (CPE) were monitored. On day 17 after inoculation, new cultures were established with the infected cells and by addition of fresh cells. Blood from the aborting mare was collected on the day of abortion and 20 days after abortion, and sera were prepared for use in virus-neutralization (VN) assays. The VN titers were determined by standard technique against 100 tissue culture infective doses 50% (TCID50%) of the first EHV-2 strain isolated in Argentina (Craig, unpublished data). To confirm the isolate as EHV-2, VN test were performed using an equine polyclonal antibody against EHV-2 and polyclonal antibodies against EHV-1, EHV-4, and equine arteritis virus (Bucyrus strain) a as controls. In addition, standard immunofluorescence (IF) test was prepared using a rabbit anti-EHV-2 polyclonal antiserum b and fluorescein isothiocyanate-labeled anti-rabbit immunoglobulin G antibody. c The restriction endonuclease (RE) analysis was done as described by Galosi et al. 11 The RK13-infected cells were treated with proteinase K, d and total DNA was extracted with phenol and phenol-chloroform-isoamylalcohol, precipitated with cold absolute alcohol and finally cleaved with BamHI. d The resultant restriction pattern obtained by agarose gel electrophoresis was compared with patterns from 2 reference articles. 1, 7 To detect EHV-2 DNA, a previously described nested PCR was used to amplify a region located upstream of the gene that encodes a product homologous to human interleukin-10. 4 A virus confirmed to be EHV-2 was isolated from RK13 cells inoculated with the lung sample from the aborted equine fetus. The CPE consisted of foci of rounded cells and were detected about 14 days after inoculation of RK13 cell monolayers, with a 1:10 dilution of the processed lung sample. In newly established, infected cell monolayers, cytopathic changes developed slowly as has been described for EHV-2 by other authors. 7 Complete CPE was not detected even after 7-10 days of incubation. The EHV-2-positive cells were demonstrated by immunofluorescent staining. No viral CPE or virus-specific fluorescence was observed on RK13 cells inoculated with liver and spleen samples from the aborted fetus or in mock-infected cells. The EHV-2 VN titers detected on both serum samples obtained from the aborting mare were high (1:512). Identity of the isolated virus (designated BB03) was confirmed by VN assay with a polyclonal antibody against EHV-2. The virus was not neutralized by antisera against EHV-1, EHV-4, or equine arteritis virus. The RE analysis with BamHI confirmed that the virus was EHV-2. 1, 7 The second round of nested PCR using EHV-2-specific primers and DNA extracted from the lung sample or from infected cells amplified a visible product of the expected size (ϳ750 bp). 4 The PCR assay was negative for DNA extracted from liver and spleen samples and for EHV-1 DNA used as a negative control.
The EHV-2 was first isolated in Argentina from equine nasal swabs in 1997. The EHV-2 has been detected in various regions of the world; however, the exact prevalence and pathogenic role of this gammaherpesvirus are still not clear. 17 In this study, the authors isolated EHV-2 from the lung of an equine aborted fetus. A long period of time (14 days) was required for the virus to replicate and produce CPE in cell culture. The high titer of neutralizing antibodies against EHV-2 present in the mare could indicate a recent exposure to the virus. There is no evidence to indicate that EHV-2 has abortigenic potential and the virus is not known to be transmitted from mare to foal via vaginal secretions and colostrum. 14, 19 Experimentally, it has been found that a pregnant mare inoculated with EHV-2 by the intrauterine route did not have any effect on the pregnancy; however, the normal newborn foal showed signs of disease at 4 days after birth. 13 Although vertical transmission of EHV-2 has not been demonstrated, it is recognized that the role of the mare in transmitting EHV-2 infections requires further investigation. 6 Viral persistence and latency are features of all herpesviruses. The EHV-2 is similar to Epstein Barr virus in that persistence and latency occur within peripheral blood mononuclear cells. 4 Some authors suggest that although EHV-2 infection is very common, the mechanism and location of persistence of the virus is not well known. 17 The authors of this study propose that the EHV-2 isolate in this study was present in the mare's leukocytes and was carried across the placenta to the fetus. Equine herpesvirus-2 is reported to belong to a heterogeneous group of viruses, and the characteristics of different strains are likely to vary and could reflect biological differences. 4, 6, 7 This work constitutes the first reported isolation of EHV-2 from an aborted equine fetus. The presence of EHV-2 in the lung of the aborted fetus would indicate that this virus crossed the placental barrier. However, it is not known whether EHV-2 was responsible for this abortion. Nevertheless, the finding of possible transplacental transmission of EHV-2 is a novel observation that should be taken into account in future studies on EHV-2.
